A Controlled Trial of Sheng-Yu-Tang for Post–Hematopoietic Stem Cell Transplantation Leukemia Patients: A Proposed Protocol and Insights From a Preliminary Pilot Study

Introduction: Hematopoietic stem cell transplantation has become a well-established treatment for hematologic disorders including acute leukemia. However, long-term survival rates following this procedure are still extremely low, due to posttransplantation relapse, infections, and graft-versus-host...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischer, Tom, Chang, Tung-Ti, Chiang, Jen-Huai, Yen, Hung-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142101/
https://www.ncbi.nlm.nih.gov/pubmed/29431027
http://dx.doi.org/10.1177/1534735418756736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142101/
https://www.ncbi.nlm.nih.gov/pubmed/29431027
http://dx.doi.org/10.1177/1534735418756736

Ejemplares similares